NCT06815120 A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent
| NCT ID | NCT06815120 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southampton |
| Condition | Catheter Blockage |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-06 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-06 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Urological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, negatively impacting on QoL and mental health. Offering novel designs with significantly lower E\&B leads to a reduction in UTIs and improves QoL. Reducing hospital admissions (from 3 to 1 per patient, annually) would free \>100,000 bed-nights, allowing the elderly to regain independence. Our proposed research could have a significant impact towards fulfilling the 'healthy-ageing' Grand Challenge. Additionally, the novel stent reduces prevalence of infections and therefore, of antibiotic prescriptions contributing to the Global AMR challenge.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18 years or over 2. Ureteric stents clinically indicated either due to kidney stones or abdominal/pelvic cancers compressing ureters 3. Previous experience with ureteric stents 4. Awaiting insersion/replacement of stents 5. Ability to give consent 6. Ability to interact with study documentation 7. Sufficient English to complete study documentations and questionnaires Exclusion Criteria: 1. Expected survival \<4months 2. Unfit for stent insertion 3. Unable to comply with study processes Pregnancy
Contact & Investigator
Ali Mosayyebi
PRINCIPAL INVESTIGATOR
University of Southampton
Frequently Asked Questions
Who can join the NCT06815120 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Catheter Blockage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06815120 currently recruiting?
Yes, NCT06815120 is actively recruiting participants. Contact the research team at a.mosayyebi@soton.ac.uk for enrollment information.
Where is the NCT06815120 trial being conducted?
This trial is being conducted at Southampton, United Kingdom, London, United Kingdom.
Who is sponsoring the NCT06815120 clinical trial?
NCT06815120 is sponsored by University of Southampton. The principal investigator is Ali Mosayyebi at University of Southampton. The trial plans to enroll 50 participants.